These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11900339)

  • 1. Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock.
    Mitsuoka H; Kistler EB; Schmid-Schönbein GW
    Shock; 2002 Mar; 17(3):205-9. PubMed ID: 11900339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic proteases and inflammatory mediators in peritoneal fluid during splanchnic arterial occlusion and reperfusion.
    Ishimaru K; Mitsuoka H; Unno N; Inuzuka K; Nakamura S; Schmid-Schönbein GW
    Shock; 2004 Nov; 22(5):467-71. PubMed ID: 15489640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic protease inhibition during shock attenuates cell activation and peripheral inflammation.
    Fitzal F; DeLano FA; Young C; Rosario HS; Schmid-Schönbein GW
    J Vasc Res; 2002; 39(4):320-9. PubMed ID: 12187122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes.
    Mitsuoka H; Kistler EB; Schmid-Schonbein GW
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1772-7. PubMed ID: 10677533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in early symptoms of shock by delayed intestinal protease inhibition.
    Fitzal F; DeLano FA; Young C; Schmid-Schönbein GW
    Arch Surg; 2004 Sep; 139(9):1008-16. PubMed ID: 15381622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic digestive enzyme blockade in the small intestine prevents insulin resistance in hemorrhagic shock.
    DeLano FA; Schmid-Schönbein GW
    Shock; 2014 Jan; 41(1):55-61. PubMed ID: 24088998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for blockade of in vivo activator production in the ischemic intestine and multi-organ failure.
    Mitsuoka H; Schmid-Schönbein GW
    Shock; 2000 Nov; 14(5):522-7. PubMed ID: 11092684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomechanical aspects of the auto-digestion theory.
    Schmid-Schönbein GW
    Mol Cell Biomech; 2008 Jun; 5(2):83-95. PubMed ID: 18589497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A journey with Tony Hugli up the inflammatory cascade towards the auto-digestion hypothesis.
    Schmid-Schönbein GW
    Int Immunopharmacol; 2007 Dec; 7(14):1845-51. PubMed ID: 18039521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma activation during splanchnic arterial occlusion shock.
    Kistler EB; Lefer AM; Hugli TE; Schmid-Schönbein GW
    Shock; 2000 Jul; 14(1):30-4. PubMed ID: 10909890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms for cell activation and its consequences for biorheology and microcirculation: Multi-organ failure in shock.
    Schmid-Schönbein GW; Kistler EB; Hugli TE
    Biorheology; 2001; 38(2-3):185-201. PubMed ID: 11381174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pancreas as a source of cardiovascular cell activating factors.
    Kistler EB; Hugli TE; Schmid-Schönbein GW
    Microcirculation; 2000 Jun; 7(3):183-92. PubMed ID: 10901497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic digestive enzyme blockade in the intestine increases survival after experimental shock.
    DeLano FA; Hoyt DB; Schmid-Schönbein GW
    Sci Transl Med; 2013 Jan; 5(169):169ra11. PubMed ID: 23345609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activating factor interaction with tumor necrosis factor and myocardial depressant factor in splanchnic artery occlusion shock.
    Zingarelli B; Squadrito F; Ioculano M; Altavilla D; Bussolino F; Campo GM; Caputi AP
    Eur J Pharmacol; 1992 Nov; 222(1):13-9. PubMed ID: 1468489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion.
    Cuzzocrea S; Zingarelli B; Costantino G; Szabó A; Salzman AL; Caputi AP; Szabó C
    Br J Pharmacol; 1997 Jul; 121(6):1065-74. PubMed ID: 9249240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocation of pancreatic juice after ischemia and reperfusion of the intestines and the effects of gabexate mesilate (FOY) in rats.
    Chen CF; Wang D; Lin HI; Shen CY; Yang NP
    Transplant Proc; 2007 May; 39(4):861-3. PubMed ID: 17524833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmural intestinal wall permeability in severe ischemia after enteral protease inhibition.
    Altshuler AE; Lamadrid I; Li D; Ma SR; Kurre L; Schmid-Schönbein GW; Penn AH
    PLoS One; 2014; 9(5):e96655. PubMed ID: 24805256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic enzymes generate cytotoxic mediators in the intestine.
    Penn AH; Hugli TE; Schmid-Schönbein GW
    Shock; 2007 Mar; 27(3):296-304. PubMed ID: 17304111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C5a receptor antagonist attenuates multiple organ injury in a model of ruptured abdominal aortic aneurysm.
    Harkin DW; Romaschin A; Taylor SM; Rubin BB; Lindsay TF
    J Vasc Surg; 2004 Jan; 39(1):196-206. PubMed ID: 14718840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabexate mesilate (FOY) inhibition of amylase and phospholipase A(2) activity in sow pancreatic juice.
    Caronna R; Loretta D; Campedelli P; Catinelli S; Nofroni I; Sibio S; Sinibaldi G; Chirletti P
    J Invest Surg; 2003; 16(6):345-51. PubMed ID: 14708545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.